CRNX Prakiraan wutah bathi kanggo taun ngarep crinetics.com

Lambang korporat lan logo Crinetics (CRNX)

High barriers to entry in the endocrine drug sector are driven by stringent FDA oversight and patent protection of compounds. The EPS growth prospects for the next fiscal year projected by the GURU.Markets system confirm this, with the 11.90 metric serving as the target level. Crinetics Pharmaceuticals (CRNX) is developing high-margin solutions for the treatment of acromegaly, anticipating powerful catalysts from the final stages of trials for new molecules.

Crinetics Pharma (CRNX): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 12.09.2026

CRNX (Crinetics Pharmaceuticals, Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:CRNX, crinetics.com
Produk dadi Crinetics

Professional managers utilize projected EPS growth to filter assets, assessing consensus earnings dynamics for the upcoming period as an indicator of operational scaling. For Crinetics Pharmaceuticals (CRNX), this metric reflects market optimism regarding the commercialization of paltusotine and the prospects of acquisition by industry behemoths, as clearly demonstrated by this chart of consensus EPS growth estimates for the following year.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SLNO: Prakiraan wutah bathi kanggo taun ngarep|FOLD - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep 89bio Pharma|Agios Corp (AGIO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep structuretx.com (GPCR)|Prakiraan wutah bathi saben saham kanggo taun ngarep mimedx.com MDXG|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MBX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Altimmune Corp - Proyeksi tambahing bathi saben saham ing taun ngarep|Aardvark Therapeutics Inc (AARD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep